Company: OSRH
Filing Date: 2025-01-29
Form Type: S-4/A
Source: 0001213900-25-007923
Chunk: 545

Company: OSR Holdings, Inc.
Filing Date: 2025-01-29
Form: S-4/A
Chunk 545
---
 |     |        |   — |     |            |          — |   |     |             |   (565,737 | ) |     |               |   (565,737 | ) |
| Net income                                                                                                                            |     |            — |     |        |   — |     |            |          — |   |     |             |    301,464 |   |     |               |    301,464 |   |
| Balance, June 30, 2023 (unaudited)                                                                                                    |     |    2,155,000 |     | $      | 216 |     | $          |          — |   |     | $           | (2,094,725 | ) |     | $             | (2,094,509 | ) |
| Remeasurement of common stock subject to redemption                                                                                   |     |            — |     |        |   — |     |            |          — |   |     |             |   (438,614 | ) |     |               |   (438,614 | ) |
| Net income                                                                                                                            |     |            — |     |        |   — |     |            |          — |   |     |             |     78,183 |   |     |               |     78,183 |   |
| Balance, September 30, 2023 (unaudited)                                                                                               |     |    2,155,000 |     | $      | 216 |     | $          |          — |   |     | $           | (2,455,156 | ) |     | $             | (2,454,940 | ) |

The accompanying notes are an integral part of the unaudited condensed financial statements.

F-4

BELLEVUE LIFE SCIENCES ACQUISITION CORP. CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)

| CASH FLOWS FROM OPERATING ACTIVITIES                                                 |     | For the Nine Months Ended 
 September 30,             
 2024                      |             |   |     | 2023 |             |   |
|:-------------------------------------------------------------------------------------|:----|:--------------------------|------------:|:--|:----|:-----|------------:|:--|
| Net loss (income)                                                                    |     | $                         |    (388,686 | ) |     | $    |     489,952 |   |
| Adjustments